Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06754436 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 31, 2024 (before its estimated November 11, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this study is to investigate the effects of ECMO-assisted therapy on L-AmB PK parameters in patients with critically ill patients of invasive fungal infections, and to determine the in vivo pharmacokinetic changes of L-AmB in the ECMO population. To establish and validate a population pharmacokinetic model for liposomal amphotericin B in patients with critically ill patients of invasive fungal infections treated with ECMO adjuvant therapy, and to explore the pharmacokinetics/pharmacodynamics of the drug with different dosing regimens.
Trial Details
NCT Number NCT06754436
Lead Sponsor Beijing Anzhen Hospital
Conditions
(from sponsor)		 Invasive Fungal Infections, Liposomal Amphotericin B
Related terms Invasive Fungal Infections
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov